scholarly journals Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation

2011 ◽  
Vol 15 (25) ◽  
Author(s):  
J Hislop ◽  
Z Quayyum ◽  
A Elders ◽  
C Fraser ◽  
D Jenkinson ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document